“India is a significant opportunity for SpinChem. The combination of rapid industry growth and an increasing need for scalable biocatalysis means our RBR technology is expanding at exactly the right time,” says Dr. Emil Byström, CEO of SpinChem.
India is the world’s third largest pharmaceutical producer by volume and accounts for roughly 20% of global generic medicine supply. The country’s pharmaceutical market, currently valued at USD 55 billion, is expected to more than double to USD 120–130 billion by 2030.
Establishing local presence
As Indian manufacturers scale production and moves toward greener pharmaceutical synthesis and manufacturing, demand for advanced biocatalysis and intensified liquid phase processing is rising.
SpinChem’s RBR technology is already used globally for these types of applications.
”We’re bringing technology that enables Indian pharmaceutical manufacturers to scale their liquid processing operations. The partnership with Smart Labtech establishes the local presence needed for us to support the innovative change in India, and it also strengthens SpinChem’s global position,” says Emil Byström.
The RBR technology addresses a real need in India
Under the partnership, Smart Labtech Private Ltd will provide SpinChem with local technical consultation and application support for Indian pharmaceutical manufacturers and research organizations.
“The rotating bed reactor technology addresses a real need across India’s pharmaceutical and chemical industry. Today’s lab models are tomorrow’s scale-up systems. Our focus is on enabling companies to transition from laboratory innovation to production-scale implementation,” says Mr. Satya Prasad, CEO, Smart Labtech.
Aligns with the new free trade agreement
The collaboration comes at a pivotal moment in EU–India relations. Following the January 2026 conclusion of the EU–India Free Trade Agreement, one of the world’s largest free trade areas covering 2 billion people, the conditions for technology transfer and industrial partnerships have significantly improved.
“The new free trade agreement creates favourable conditions for European Indian technology partnerships like this one,” says Tove Näsman, Business Manager, SpinChem AB. ”Within this broader EU–India framework, our partnership embodies Sweden’s ‘Made with Sweden’ initiative, which prioritizes genuine collaboration over simply exporting products”.
About – SpinChem® AB
SpinChem develops rotating bed reactor technology that intensifies liquid-phase processes in industrial, environmental, and regulated applications. With a vision to catalyse transformation of the global process industry through simple, fast, and sustainable technical solutions, SpinChem is headquartered in Umeå, Sweden, and exports to more than 40 countries.
About – Smart Labtech Private Ltd
Smart Labtech Private Ltd manufactures and supplies laboratory analytical, biotechnological, environmental, and weighing equipment for R&D and quality control laboratories across India. Based in Hyderabad with a pan-India network built over two decades, the company provides technical expertise to customers in the pharmaceutical, chemical, and biotechnology industries throughout India.
For more information:
Dr. Emil Byström, CEO SpinChem AB
Email: info@spinchem.com
Phone: +46 70-689 2501